Evidence map›Paper›PMID 26943029›Full record

ArticleOncotarget2016

Renal cell carcinoma alters endothelial receptor expression responsible for leukocyte adhesion.

Eva Juengel, Geraldine Krueger, Jochen Rutz, Karen Nelson, Isabella Werner, Borna Relja, Barbara Seliger, Beate Fisslthaler, Ingrid Fleming, Igor Tsaur and 2 more

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Eva JuengelDepartment of Urology, Goethe-University Hospital, Frankfurt am Main, Germany.
Geraldine KruegerDepartment of Urology, Goethe-University Hospital, Frankfurt am Main, Germany.
Jochen RutzDepartment of Urology, Goethe-University Hospital, Frankfurt am Main, Germany.
Karen NelsonDepartment of Vascular and Endovascular Surgery, Goethe-University Hospital, Frankfurt am Main, Germany.
Isabella WernerDepartment of Thoracic, Cardiac and Vascular Surgery, Goethe-University Hospital, Frankfurt am Main, Germany.
Borna ReljaDepartment of Trauma, Hand and Reconstructive Surgery, Goethe-University Hospital, Frankfurt am Main, Germany.
Barbara SeligerInstitute for Medical Immunology, Medical Faculty, Martin Luther University, Halle, Germany.
Beate FisslthalerInstitute for Vascular Signalling, Centre for Molecular Medicine, Goethe-University, Frankfurt am Main, Germany.
Ingrid FlemingInstitute for Vascular Signalling, Centre for Molecular Medicine, Goethe-University, Frankfurt am Main, Germany.
Igor TsaurDepartment of Urology, Goethe-University Hospital, Frankfurt am Main, Germany.
Axel HaferkampDepartment of Urology, Goethe-University Hospital, Frankfurt am Main, Germany.
Roman A BlahetaDepartment of Urology, Goethe-University Hospital, Frankfurt am Main, Germany.
Goethe University Frankfurt · DEUniversity Hospital Frankfurt · DEMartin Luther University Halle-Wittenberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal cell carcinoma (RCC) escapes immune recognition. To elaborate the escape strategy the influence of RCC cells on endothelial receptor expression and endothelial leukocyte adhesion was evaluated. Human umbilical vein endothelial cells (HUVEC) were co-cultured with the RCC cell line, Caki-1, with and without tumor necrosis factor (TNF)-alpha. Intercellular cell adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), endothelial (E)-selectin, standard and variants (V) of CD44 were then analysed in HUVEC, using flow cytometry and Western blot analysis. To determine which components are responsible for HUVEC-Caki-1 interaction causing receptor alteration, Caki-1 membrane fragments versus cell culture supernatant were applied to HUVECS. Adhesion of peripheral blood lymphocytes (PBL) and polymorphonuclear neutrophils (PMN) to endothelium was evaluated by co-culture adhesion assays. Relevance of endothelial receptor expression for adhesion to endothelium was determined by receptor blockage. Co-culture of RCC and HUVECs resulted in a significant increase in endothelial ICAM-1, VCAM-1, E-selectin, CD44 V3 and V7 expression. Previous stimulation of HUVECs with TNF-alpha and co-cultivation with Caki-1 resulted in further elevation of endothelial CD44 V3 and V7 expression, whereas ICAM-1, VCAM-1 and E-selectin expression were significantly diminished. Since Caki-1 membrane fragments also caused these alterations, but cell culture supernatant did not, cell-cell contact may be responsible for this process. Blocking ICAM-1, VCAM-1, E-selectin or CD44 with respective antibodies led to a significant decrease in PBL and PMN adhesion to endothelium. Thus, exposing HUVEC to Caki-1 results in significant alteration of endothelial receptor expression and subsequent endothelial attachment of PBL and PMN.

Indexed as

Carcinoma, Renal CellCell AdhesionCell Adhesion MoleculesCell ProliferationCells, CulturedCoculture TechniquesE-SelectinHumansHuman Umbilical Vein Endothelial CellsHyaluronan ReceptorsIntercellular Adhesion Molecule-1Kidney NeoplasmsLeukocytesTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1CD44 protein, humanCell Adhesion MoleculesE-SelectinHyaluronan ReceptorsIntercellular Adhesion Molecule-1Tumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1adhesionendothelial receptor expressionleukocytesrenal cell carcinomatumor immune escape

Identifiers

PMID26943029
PMCPMC4991464
OpenAlexW2333445066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.